260 Avoiding IVF’s Next Public Catastrophe. Dr. Tex VerMilyea & Moises Eilemberg
Description
They were lucky.
The gas to the incubator stopped flowing, but XiltriX caught the failure in time, no embryos were lost… and no headlines were made.
But what happens if the next failure isn’t?
In this episode, Dr. Matthew “Tex” VerMilyea of Ovation and US Fertility, and Moises Eilemberg, CEO of XiltriX North America, return to Inside Reproductive Health to ask a hard question:
What would your lab do in a crisis?
You’ll hear:
The catastrophic loss Sweden’s biobank suffered (and what you need to learn from it)
Why embryologist shortages are reshaping the IVF lab
What standardizing monitoring protocols could mean for your network
Why Tex believes monitoring as a service is the future
The steps to take after a public lab failure (and how to avoid needing them)
How XiltriX helps fertility labs gain 24/7 visibility, rapid response alerts, and peace of mind
This isn’t about tech. It’s about protecting the future of your lab, your brand, and your patients.
United States
